Last summer, Northwestern University researchers introduced the first-ever transient pacemaker — a fully implantable, wireless device that harmlessly dissolves in the body after it’s no longer needed. Now, they unveil a new, smart version that is integrated into a coordinated network of four soft, flexible, wireless, effects of tamoxifen on fetus wearable sensors and control units placed around the upper body.
The study will be published Friday (May 27) in the journal Science. The work was led by Northwestern’s John A. Rogers, Igor R. Efimov and Dr. Rishi Arora.
The sensors communicate with each other to continuously monitor the body’s various physiological functions, including body temperature, oxygen levels, respiration, muscle tone, physical activity and the heart’s electrical activity.
The system then uses algorithms to analyze this combined activity in order to autonomously detect abnormal cardiac rhythms and decide when to pace the heart and at what rate. All this information is streamed to a smartphone or tablet, so physicians can remotely monitor their patients.
The new transient pacemaker and sensor/control network can be used in patients who need temporary pacing after cardiac surgery or are waiting for a permanent pacemaker. The pacemaker wirelessly harvests energy from a node within the network — a small wireless device that softly adheres to the patient’s chest. This technology eliminates the need for external hardware, including wires (or leads).
To enable the system to communicate with the patient, the researchers incorporated a small, wearable haptic-feedback device that can be worn anywhere on the body. When the sensors detect an issue (such as low battery power, incorrect device placement or pacemaker malfunction), the haptic device vibrates in specific patterns that alert wearers and inform them of the problem.
Source: Read Full Article